Kuczynski Elizabeth A, Carnevalli Larissa, Sinclair Charles
AstraZeneca, Cambridge CB2 0AA, UK.
AstraZeneca, Cambridge CB2 0AA, UK.
STAR Protoc. 2023 Mar 9;4(2):102144. doi: 10.1016/j.xpro.2023.102144.
T cell hematological cancer has a complex interplay with host immune cells, but the ability to experimentally discriminate transferred cancer cells from host cells by flow cytometry is technically challenging. Here, we present a flow cytometry protocol to evaluate cancer cell and host immune phenotypes following transplant of a T cell lymphoma bearing a congenic marker (CD45.2) into a syngeneic host (CD45.1). We describe steps for isolation of primary immune cells from mice, staining preparation with flow cytometry antibody cocktails, and analysis by flow cytometry. For complete details on the use and execution of this protocol, please refer to Kuczynski et al..
T细胞血液系统癌症与宿主免疫细胞之间存在复杂的相互作用,但通过流式细胞术在实验上区分转移的癌细胞与宿主细胞的能力在技术上具有挑战性。在这里,我们提出了一种流式细胞术方案,用于评估将携带同基因标记(CD45.2)的T细胞淋巴瘤移植到同基因宿主(CD45.1)后癌细胞和宿主免疫表型。我们描述了从小鼠中分离原代免疫细胞、用流式细胞术抗体混合物进行染色准备以及通过流式细胞术进行分析的步骤。有关该方案的使用和执行的完整详细信息,请参考库钦斯基等人的研究。